Electrophysiological study prior to planned pulmonary valve replacement in patients with repaired tetralogy of Fallot

Benjamin Bouyer, Zakaria Jalal, F. Daniel Ramirez, Nicolas Derval, Xavier Iriart, Josselin Duchâteau, François Roubertie, Nadir Tafer, Romain Tixier, Thomas Pambrun, Ghassen Cheniti, Ciro Ascione, Masaaki Yokoyama, Christopher Kowalewski, Samuel Buliard, Rémi Chauvel, Marine Arnaud, Mélèze Hocini, Michel Haïssaguerre, Pierre Jaïs, Hubert Cochet, J.-b. Thambo, Frédéric SacherJournal of Cardiovascular Electrophysiology 2023 · DOI

TL;DR

This study investigates the utility of electrophysiological studies (EPS) before pulmonary valve replacement (PVR) in patients with repaired Tetralogy of Fallot (rTOF). They found that preoperative EPS can effectively identify patients at higher risk of ventricular arrhythmias (VAs), enabling targeted ablation and informing decisions about implantable cardioverter-defibrillator (ICD) implantation, ultimately aiming to reduce sudden cardiac death.

What Problem Does This Paper Address?

Patients with repaired Tetralogy of Fallot (rTOF) have a significantly increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias (VAs), which remain the leading cause of mortality in this population. However, current methods for stratifying this risk, such as QRS duration and clinical history, have limited predictive value. This leaves a critical gap in identifying which patients are most vulnerable and could benefit from early intervention. The authors propose that performing an electrophysiological study (EPS) before planned pulmonary valve replacement (PVR) could offer a more precise risk assessment and an opportune moment to intervene, as PVR is a common procedure for these patients and can be combined with electrophysiological procedures.

Methods

The researchers conducted a prospective study involving 77 consecutive patients with rTOF scheduled for PVR. The core of their methodology involved:

  • Electrophysiological Study (EPS) and Ventricular Stimulation (PVS): Before PVR, all patients underwent an EPS. This involved programmed ventricular stimulation (PVS) from two different sites to induce ventricular arrhythmias. If not inducible at baseline, PVS was repeated after isoproterenol administration.
  • Electrophysiological Mapping: During EPS, detailed electroanatomical mapping of the right ventricle was performed to identify areas of scar tissue and slow conduction, which are known substrates for reentrant ventricular tachycardia in rTOF.
  • Ablation Strategies: When patients were inducible or had evidence of slow conduction in critical anatomical isthmuses (Als), catheter ablation (radiofrequency) was performed. If endocardial ablation was unsuccessful or not attempted, surgical cryoablation was considered, often during the PVR procedure itself.
  • Risk Stratification: Patients were assessed using established risk factors for VA, including QRS duration, ejection fractions (LVEF and RVEF), and a non-invasive risk score model (PREVENTION ACHD).
  • ICD Implantation Decisions: Decisions regarding ICD implantation were made based on inducibility during EPS, acute ablation success, and the presence of other risk factors.
  • Follow-up: Patients were followed for a mean of 74 months to assess for the occurrence of sustained VAs, appropriate ICD therapy, and SCD.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Pre-PVR EPS as a Critical Window: The study highlights that the period just before PVR is a particularly vulnerable time for rTOF patients, making it an opportune moment for EPS due to potential hemodynamic stresses.
  • Ablation as a Proactive Measure: Combining EPS with ablation (either percutaneous or surgical) during the PVR process offers a chance to address the underlying arrhythmic substrate before significant events occur.
  • Anatomical Isthmus (AI) Type 3 as a Common Target: The study identified AI type 3 (bordered by the ventricular septal defect patch and pulmonary valve annulus) as the most frequently involved in arrhythmia circuits and thus the most common target for ablation. This is likely due to its consistent presence in rTOF anatomy.
  • Inducibility as a Strong Predictor: The most striking finding is the strong correlation between inducibility of VAs during the initial EPS and the occurrence of sustained VTs during follow-up. Non-inducible patients had a significantly lower risk.
  • ICD Implantation Guidance: While non-invasive risk scores exist, EPS provides a more direct measure of risk. The study suggests EPS can refine ICD implantation decisions, particularly in cases where risk factors are borderline or inducibility is present.

Key Results

  • Inducibility Rate: Out of 77 patients, 18 (24%) were inducible for ventricular arrhythmias during the initial EPS.
  • Ablation Success: Ablation was performed in 28 patients, with most achieving non-inducibility at the end of the procedure.
  • Follow-up Outcomes: Over a mean follow-up of 74 months, no sudden cardiac deaths occurred. However, three patients who were inducible at the initial EPS experienced sustained VTs, compared to none in the non-inducible group (p < .001).
  • ICD Implantation: Five patients received ICDs, four for primary prevention and one for secondary prevention.
  • Risk Factor Correlation: Inducible patients had a higher number of arrhythmic risk factors and lower RVEF compared to non-inducible patients.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Number of Events: The relatively small number of VAs and ICD events limits the statistical power to draw definitive conclusions.
  • Referral Bias: The study population was drawn from a tertiary referral center, which may not be representative of the broader rTOF population.
  • Historical Cohort: The study included patients from 2010-2018, and the current management of rTOF may have evolved.
  • Protocol Differences: The coupling interval used in their PVS protocol differed from some previous studies, potentially affecting the number of inducible arrhythmias.

Future work could focus on larger, prospective studies to confirm these findings, refine risk stratification models, and explore the long-term impact of combined PVR and electrophysiological interventions on patient outcomes. The authors also suggest that systematic control of isthmus block 3-6 months post-procedure might be beneficial, especially for inducible patients who did not receive an ICD.

Summary updated

Abstract

Preoperative EPS can help identifying patients with rTOF at risk for VAs, providing an opportunity for targeted ablation and may improve decision-making regarding ICD implantation.
BibTeX
@article{bouyer2023electrophysiological,
  author = {Benjamin Bouyer and Zakaria Jalal and F. Daniel Ramirez and Nicolas Derval and Xavier Iriart and Josselin Duchâteau and François Roubertie and Nadir Tafer and Romain Tixier and Thomas Pambrun and Ghassen Cheniti and Ciro Ascione and Masaaki Yokoyama and Christopher Kowalewski and Samuel Buliard and Rémi Chauvel and Marine Arnaud and Mélèze Hocini and Michel Haïssaguerre and Pierre Jaïs and Hubert Cochet and J.-B. Thambo and Frédéric Sacher},
  title = {{Electrophysiological study prior to planned pulmonary valve replacement in patients with repaired tetralogy of Fallot}},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2023},
  doi = {10.1111/jce.15940},
}

Loading related content...

Figure